  Abbreviations, acronyms & symbols                                                                                                                    
  ----------------------------------- --------------------------------------------------------- ------ ----------------------------------------------- --------------------
  AUC                                 = Area under the ROC curve                                       LR                                              = Likelihood ratio
  AVR                                 = Aortic valve replacement                                LVEF   = Left ventricular ejection fraction            
  CI                                  = Confidence interval                                     NYHA   = New York Heart Association                    
  COPD                                = Chronic obstructive pulmonary disease                   ROC    = Receiver operating characteristic             
  EuroSCORE                           = European System for Cardiac Operative Risk Evaluation   SPSS   = Statistical Package for the Social Sciences   
  GAV                                 = German Aortic Valve                                     TAVI   = Transcatheter aortic valve implantation       

INTRODUCTION
============

The assessment of operative risk is mandatory for all cardiac procedures, since patients need to be informed preoperatively about the risks and surgeons must weigh up pros and cons of a certain procedure. In this scenario, risk scoring systems are used to predict and evaluate results.

Although there are widely spread risk scores, such as the European System for Cardiac Operative Risk Evaluation (EuroSCORE)^\[[@r1]\]^, that have demonstrated good predictive accuracy in the field of cardiovascular surgery, the trend of the moment is for more specific scores to be applied to more specific contexts in cardiac surgery.

Könning et al.^\[[@r2]\]^ published in 2013 the German Aortic Valve (GAV) score. It was designed for fair and reliable outcome evaluation, allows comparison of predicted and observed mortality for conventional aortic valve replacement (AVR) and transcatheter aortic valve implantation (TAVI) in low-, moderate-, and high-risk groups, enables a risk-adjusted benchmark of outcome, and fosters the efforts for continuous improvement of quality in aortic valve procedures.

Since the score has never been tested in Brazil, we aimed to validate the GAV score in patients who underwent conventional AVR at a Brazilian center.

METHODS
=======

Patients who underwent conventional AVR between January 2015 and December 2018 were included in the study. Those who underwent concomitant procedures or TAVI were excluded. Data were collected and analyzed retrospectively. Primary endpoint was in-hospital mortality. Patients' GAV scores were calculated according to the criteria described by Kötting et al.^\[[@r2]\]^ ([Figure 1](#f1){ref-type="fig"}). The score is calculated through the sum of regression coefficients, which corresponds to a certain expected operative mortality.

Fig. 1German Aortic Valve (GAV) score.COPD=chronic obstructive pulmonary disease; LVEF=left ventricular ejection fraction; NYHA=New York Heart Association

Sensitivity and specificity were assessed through the receiver operating characteristic (ROC) curve. The discrimination measures the capacity of a model (in this case, the GAV score) to differentiate between the individuals of a sample who suffer an event (in this case, death) from those who do not. The discriminative capacity of the model was estimated by means of the area under the ROC curve (AUC). Calibration of the GAV score was assessed by the Hosmer-Lemeshow test. The calibration is considered to be poor if the test is statistically significant. For the analysis, the Statistical Package for the Social Sciences (SPSS)^®^ software (SPSS, Inc., Chicago, IL, United States of America), version 15.0, for Windows^®^ was used. *P*-values \< 0.05 were considered statistically significant.

RESULTS
=======

We evaluated 224 isolated AVR procedures in adult patients. The mortality rate was 8.04% (18 patients). The patients' mean age was 58.2±19.3 years and 25% of them were female (56 patients).

Mean GAV score was 1.73±5.86 (min: 0.0; max: 3.53). The GAV score showed excellent discriminative capacity (AUC 0.925, 95% confidence interval \[CI\] 0.882-0.956; *P*\<0.001) ([Figure 2](#f2){ref-type="fig"}). The calibration of the model was tested by the Hosmer-Lemeshow method. The derived *P*-value of 0.687 confirmed a valid accordance of predicted and observed mortality, which means good calibration of the model.

Fig. 2Receiver operating characteristic (ROC) curve - Accuracy.AUC=area under the ROC curve; GAV=German Aortic Valve

The cutoff "1.8"turned out to be the best discriminatory point with the best combination of sensitivity (88.9%) and specificity (75.7%) to predict operative death ([Table 1](#t1){ref-type="table"}).

###### 

Best discriminatory point of the German Aortic Valve score.

  Score     Sensitivity   95% CI        Specificity   95% CI        +LR     -LR
  --------- ------------- ------------- ------------- ------------- ------- -------
  ≥ 0.4     100           81.5 - 100    \-            0.0 - 1.8     1        
  \> 1.1    100           81.5 - 100    57.77         50.7 - 64.6   2.37    \-
  \> 1.4    94.44         72.7 - 99.9   67.96         61.1 - 74.3   2.95    0.082
  \> 1.8    88.89         65.3 - 98.6   75.73         69.3 - 81.4   3.66    0.15
  \> 2.3    72.22         46.5 - 90.3   87.38         82.1 - 91.6   5.72    0.32
  \> 2.9    72.22         46.5 - 90.3   91.26         86.5 - 94.7   8.27    0.30
  \> 3.7    55.56         30.8 - 78.5   99.03         96.5 - 99.9   57.22   0.45
  \> 4.7    50            26 - 74       100           98.2 - 100            0.50
  \> 11.9   \-            0.0 - 18.5    100           98.2 - 100            1

CI=confidence interval; ± LR=positive/negative likelihood ratio

DISCUSSION
==========

The presumption that a scoring system might be comprehensive enough for all patients and cardiovascular surgical procedures could not be further from the truth^\[[@r3],[@r4]\]^. For instance, the widely used EuroSCORE was based on a data set consisting mainly of coronary artery bypass surgeries. Thus, such score might be less well adapted to aortic procedures than a specific score as the one evaluated in the present study. Such aspects have been highlighted by other authors as well^\[[@r5]-[@r8]\]^.

Kalender et al.^\[[@r9]\]^ tested for the first time the GAV score out of Germany, studying only 35 isolated AVR procedures in adult patients in Turkey. The patients' mean age was 61.14±13.25 years (range 29-80 years). The number of female patients was 14 (40%). Mean GAV score was 1.05±0.96 (min: 0; max: 4.98) and mean EuroSCORE II was 2.30±2.60 (min: 0.62, max: 2.30). The GAV score scale showed modest discriminative capacity (AUC 0.647, 95% CI 0.439-0.854).

To the best of our knowledge, our study is the first one to report the results of the GAV score in a Latin American scenario. It is well known that predictive models work best in the series at the location where it was developed. For this reason, the GAV score fits best to the population in Germany. Nevertheless, despite the differences between German and Brazilian populations, the score also showed a very good discriminative capacity in our population.

Limitation
----------

The major limitations of our study were its non-randomized and retrospective design, single institution setting, and the fact that our hospital is a multi-surgeon one.

CONCLUSION
==========

The GAV score applies to our population with high predictive accuracy and could be used in our population to calculate operative risk.
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